ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials

ASN Podcast
25/07/2016 23 min
ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials

Listen "ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials"

Descargar episodio Ver en sitio original

Episode Synopsis

ASN Executive Vice President, Tod Ibrahim and ASN Past President, Jonathan Himmelfarb, MD, FASN, speak with Jonca Bull, MD and Patrick Archdeacon, MD from the FDA about ways to improve disparities in clinical trials.

More episodes of the podcast ASN Podcast

Government Shutdowns & Contingency Plans: Who's Still on Duty? (Policy Update October 2025) 02/10/2025
Research Funding, Senate Letter, and a Looming Shutdown (Policy Update September 2025) 26/09/2025
Safe Catheter Connections and New Techniques (Guest: Aisha Shaikh, MBBS) 23/09/2025
EP&R Episode Two 17/09/2025
The Infection Prevention & Transitions of Care Series: Catheter Care in Hemodialysis (Guest: Namrata Krishnan, MBBS) 09/09/2025
EP&R Episode One 03/09/2025
nephSAP Guest Editor Interview: Parathyroidectomy for Treatment of Hyperparathyroidism in Chronic Kidney Disease 20/08/2025
Nephrology in the Era of McCarthyism: Heroes and Villains 06/08/2025
From the Shire to the Senate: The Big Beautiful Bill's Impact on Kidney Health Policy (Policy Update July 2025) 24/07/2025
The Smartest Guy in the Room: Bud Rose and the Invention of UpToDate 08/07/2025
漏 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA